Emmanouil Angelakis; Esam I Azhar; Fehmida Bibi; Muhammad Yasir; Ahmed K Al-Ghamdi; Ahmad M Ashshi; Adel G Elshemi; Didier Raoult ...

The company is advancing its Phase I/II trial and exploring accelerated approval pathways in the US and Europe.

NT: Not tested; TCID: Tissue culture infectious dose. 2 Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia 3 Department of Medical ...